Osteoarthritis affects 600 million people worldwide, making it a leading cause of disability. With no disease-modifying treatments available or on the horizon, oral non-steroidal anti-inflammatory ...
The removal of the contraindication to screen for hypersensitivity to blood and blood products is expected to improve workflow efficiency for health care professionals. The Food and Drug ...
People who are newly diagnosed with knee or hip osteoarthritis continue to take non-steroidal anti-inflammatory drugs (NSAIDs) despite contraindications, a new study shows. A team from Boston ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results